Division of Medical Physics, University of Leeds, Leeds, UK.
Clin Radiol. 2013 Sep;68(9):887-94. doi: 10.1016/j.crad.2013.03.015. Epub 2013 Apr 29.
To assess the effect of cryoablation on renal cell carcinoma (RCC) perfusion and single kidney (SK) glomerular filtration rate (GFR) using dynamic contrast-enhanced (DCE) magnetic resonance imaging (MRI).
Eighteen patients undergoing percutaneous cryoablation of a solitary RCC between August 2010 and November 2011 were evaluated with DCE-MRI immediately before and 1 month post-cryoablation. DCE-MRI data were acquired with 2 s temporal resolution in a coronal plane during the first pass of a 0.1 mmol/kg bolus dose of Gd-DOTA. Perfusion of the RCC (in ml/min/100 ml tissue) was estimated using a maximum slope technique. An index of SK GFR (SK-GFRi) was assessed using data acquired every 30 s for the following 3 min in the axial plane and analysed using Rutland-Patlak plots. This was compared to the GFR estimated by creatinine clearance (eGFR).
Perfusion in the zone of ablation decreased significantly (p<0.001) from a mean of 98.0 ± 37.5 ml/min/100 ml pre-cryoablation to 11.6 ± 4.1 ml/min/100 ml post-cryoablation; a mean decrease of 88.2%. Functional analysis was performed in seventeen patients. eGFR was underestimated by SK-GFRi which decreased significantly in tumour-bearing (-31.7%, p = 0.011), but not in contralateral kidneys (-4.4%, p = 0.14).
It is feasible to measure RCC perfusion pre- and post-cryoablation using DCE-MRI. The significant decrease within the zone of ablation suggests that this technique may be useful for assessment of treatment response. Further work is required to address the underestimation of eGFR by SK-GFRi and to validate the perfusion findings.
利用动态对比增强磁共振成像(DCE-MRI)评估经皮冷冻消融术治疗单个肾细胞癌(RCC)前后的肿瘤组织和对侧肾脏的血流灌注和肾小球滤过率(GFR)的变化。
2010 年 8 月至 2011 年 11 月,18 例行经皮冷冻消融术的孤立性 RCC 患者在术前和术后 1 个月分别进行 DCE-MRI 检查。冠状位快速扫描序列在经皮注射 Gd-DOTA 造影剂后进行,时间分辨率为 2 秒,获取肿瘤组织和对侧肾脏的血流灌注数据。采用最大斜率法估算肿瘤组织的血流灌注值(ml/min/100ml 组织)。利用轴位图像在 3 分钟内每 30 秒采集 1 次数据,采用 Rutland-Patlak 法分析对侧肾脏的 GFR(SK-GFRi),并与用血清肌酐清除率(eGFR)估算的 GFR 进行比较。
在肿瘤组织的消融区域,灌注值明显下降(p<0.001),从术前的 98.0±37.5ml/min/100ml 降至术后的 11.6±4.1ml/min/100ml,平均下降 88.2%。17 例患者进行了功能分析。SK-GFRi 低估了 eGFR,肿瘤侧肾脏的 GFR 显著下降(-31.7%,p=0.011),而对侧肾脏的 GFR 没有明显变化(-4.4%,p=0.14)。
DCE-MRI 可用于术前和术后测量 RCC 肿瘤组织的血流灌注。消融区域内的血流灌注值明显下降提示,该技术可能有助于评估治疗效果。需要进一步研究来解决 SK-GFRi 低估 eGFR 的问题,并验证灌注值的变化。